Tortorelli C, Gongora C, Mathe D, et al1179 Efficacy study of STC-1010 antitumor vaccine associated with standard chemotherapies on MC 38 syngeneic colon cancer tumor modelJournal for ImmunoTherapy of Cancer 2022;10 http://dx.doi.org/10.1136/jitc-2022-SITC2022.1179
Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system with visible and multi-specific targets
Selection criteria of starting material (Allogeneic tumor cell lines)
Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system with a broad & higher quality range of tumor antigens
